{"database": "lobbying", "table": "lobbying_activities", "rows": [[1311639, "cd8032b6-ed4e-4017-a0d3-3bad5b7cc506", "Q3", "340B HEALTH", 316434, "340B HEALTH", 2012, "third_quarter", "PHA", "Discussing the importance of the 340B drug discount program and improving program oversight.  Advocating for extension of program to the inpatient setting and repeal of the orphan drug ban.", "HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office", null, 235879, 0, 0, "2012-10-19T14:14:17.473000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1311639"], "units": {}, "query_ms": 5.506583023816347, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}